GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (FRA:5V7) » Definitions » 3-Year EPS without NRI Growth Rate

VentriPoint Diagnostics (FRA:5V7) 3-Year EPS without NRI Growth Rate : 16.20% (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is VentriPoint Diagnostics 3-Year EPS without NRI Growth Rate?

VentriPoint Diagnostics's EPS without NRI for the three months ended in Sep. 2023 was €-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 16.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 28.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of VentriPoint Diagnostics was 62.10% per year. The lowest was -114.00% per year. And the median was 21.90% per year.


Competitive Comparison of VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate falls into.



VentriPoint Diagnostics 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


VentriPoint Diagnostics  (FRA:5V7) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


VentriPoint Diagnostics 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics (FRA:5V7) Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics (FRA:5V7) Headlines

No Headlines